Biological and Medicinal Chemistry

Repurposing Therapeutics for the Wuhan Coronavirus nCov-2019: Supercomputer-Based Docking to the Viral S Protein and Human ACE2 Interface

Authors

Abstract

The novel Wuhan coronavirus (nCov-2019) has been sequenced, and the virus shares substantial similarity with SARS-CoV. Here, using a computational model of the spike protein (S-protein) nCov-2019 interacting with the human ACE2 receptor, we make use of the world's most powerful supercomputer, SUMMIT, to enact an ensemble docking virtual high-throughput screening campaign and identify small-molecules which may be repurposed to disrupt host-virus interactions. A ranked list of compounds is given that can be tested experimentally.

Version notes

Version 1.00

Content

Thumbnail image of coronavirus_MDS_JCS_2-14-2020_BioXriv.pdf

Supplementary material

Thumbnail image of SI.tar.tgz
SI.tar